Plain-English translation of NCT07434726 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
When your heart stops beating in the hospital, doctors perform CPR and other emergency treatments. This trial is testing whether adding a special balloon catheter โ called REBOA โ can help save more lives. The balloon is placed through a small tube in your groin and temporarily blocks blood flow in a major artery to help direct blood to your brain and heart during resuscitation.
In-hospital cardiac arrest is life-threatening, and despite the best standard care, many patients do not survive. Researchers believe that this balloon treatment might improve blood flow to vital organs during an emergency, potentially giving patients a better chance of survival.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you experience cardiac arrest in the hospital and are enrolled, you will be randomly assigned to receive either standard emergency resuscitation alone, or standard resuscitation plus the balloon catheter treatment. The research team will place the balloon catheter if you are in the treatment group, working alongside your resuscitation team. Your participation ends once your immediate medical crisis is addressed and you are stabilized or transferred to intensive care.
AI-generated summary from trial data ยท Aug 2, 2026 ยท Not medical advice
Switzerland
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment target
~98 participants
Started
April 2026
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Wolf E Hautz, MD, MME
Inselspital University Hospital Bern
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.